The Global Health Observatory

Explore a world of health data

Table
Indicator name:
Availability of at least one anti-dementia medication approved for on-label use reimbursement
Indicator Id:
5147
Rationale:
Antidementia medication may be offered for the treatment of Alzheimer's disease and certain other types of dementia, where evidence is available. The availability of reimbursable medication and care products supports the care of people with dementia and improvements in their quality of life.
Definition:
Indicates whether any of the nationally approved medications used in the treatment of Alzheimer's disease and dementia are reimbursable for on-label usage
Method of estimation:
All antidementia medications, care products and equipment that are used in the management of dementia, provided by the national authority's response
Data Type Representation:
Categorical
IMRID:
5147
Original Submeasure:
Is at least one of the anti-dementia drugs reimbursable for on-label use?
Indicator Metadata Registry List
Availability of at least one anti-dementia medication approved for on-label use reimbursement
If you have any feedback, you are welcome to write it here.
If you need to access the old Global Health Observatory data, you can do it here. But before you leave, please provide us your feedback about our new data portal.